Advanced Development of Multivalent Filovirus Vaccines
$4,000,000N01FY2013AINIH
Janessen Vaccines And Prevention, Bv, Leiden
Investigators
Abstract
This contract supports advanced development of a multivalent filovirus (biodefense) vaccine that could address both Ebola and Marburg viruses; support may be provided through early clinical development of the filovirus vaccine candidate.
View original record on NIH RePORTER →